Moderate Psoriasis
Cal/BDP cream preferred over foam formulation among patients with psoriasis
Calcipotriol/betamethasone dipropionate, or CAL/BDP, combination cream vs. foam had higher satisfaction ratings among patients with psoriasis, suggesting the cream formulation may increase adherence, according to a study.
Epidemiology and Classification of Psoriasis
VIDEO: Deucravacitinib an ‘exciting’ oral molecule for psoriasis
In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the TYK2 inhibitor deucravacitinib from the Maui Derm 2024 meeting, examining its use as a treatment for psoriasis.
Nicotinamide riboside reduces inflammation in healthy controls, patients with psoriasis
Elevating nicotinamide adenine dinucleotide with nicotinamide riboside supplementation reduced inflammation in both healthy controls and patients with psoriasis, according to findings from a clinical study.
Four popular headlines to highlight Psoriasis Action Month
Earlier this month, Healio Dermatology posted a compilation of eight popular reads to kickoff Psoriasis Action Month in psoriasis research, advocacy and FDA news.
Psoriasis resource, guidelines top dermatology stories this week
A resource on new developments in psoriasis in recognition of Psoriasis Action Month was the most popular story of the week at Healio Dermatology.